IMWG: Drug Costs and Access
IMWG Myeloma Experts debate the latest trends in treatment
June 10, 2015
Vienna, Austria
Drs. Brian Durie, Joseph Mikhael, Ola Landgren, and Paul Richardson discuss the challenges of drugs costs and access for multiple myeloma patients in 2015 and beyond.
Previous Post
What are the practical details of FISH testing?
Next Post
IMWG: The Challenge of Double Refractory Disease